We want to tackle the world's greatest health challenges
First established in 1976, MSD Ballydine develops and supplies the active ingredients and final formulated product for a range of innovative medicines at its manufacturing and R&D facilities. MSD’s first site in Ireland, the Ballydine site is MSD’s primary small molecule pipeline commercialisation facility globally, operating as a European hub for quality, manufacturing, and engineering. Its highly skilled teams leads the way in the development of new medicines and innovative treatments with the site exporting to over 25 countries around the world.